Unlike in EOMG, >80% of patients with thymomas have autoantibodies to non-AChR skeletal muscle antigens (titin and RYRs) and others that neutralise such cytokines as type I interferons (~70% [22, 61, 62] and IL-12) (Table 1). The gene discussed is TTN; the disease is thymoma.